Literature DB >> 15249450

The natural history of radiographically occult bronchogenic squamous cell carcinoma: a retrospective study of overdiagnosis bias.

Masami Sato1, Yasuki Saito, Chiaki Endo, Akira Sakurada, David Feller-Kopman, Armin Ernst, Takashi Kondo.   

Abstract

OBJECTIVE: An overdiagnosis bias occurs with the diagnosis of a disease that does not produce signs or symptoms before the patient dies from other causes. We sought to determine whether overdiagnosis bias is a factor when screening for squamous cell carcinoma of the lung.
DESIGN: Retrospective study of the Miyagi Population-Based Lung Cancer Screening Registry for high-risk patients who were seen between January 1, 1982 (when sputum cytology tests were added for men with long smoking histories), and December 31, 1996.
SETTING: Miyagi Prefecture, Japan. PATIENTS: A total of 251 patients (all men) who had sputum cytology test results that were positive for squamous cell carcinoma but had normal radiograph findings, 44 of whom declined cancer treatment (mean age, 70 years) and 207 of whom were treated with resection within 12 weeks of diagnosis (mean age, 65.5 year). END POINTS: Five-year and 10-year survival rates from primary lung cancer in both groups as of August 15, 2001.
RESULTS: Among the 44 untreated patients, 15 (34%) remained asymptomatic. The survival rate due to primary lung cancer death in the untreated group was 53.2% at 5 years and 33.5% at 10 years. The survival rate among treated patients was 96.7% at 5 years and 94.9% at 10 years. Of the 125 treated patients who died, 14 (11.2%) died from primary lung cancer.
CONCLUSION: Given that the two thirds of the untreated patients with squamous cell carcinoma of the bronchus died from lung cancer within 10 years, overdiagnosis bias does not appear to be a factor in screening for this disease. Thus, we recommend that patients with radiographically occult squamous cell carcinoma of the bronchus undergo tumor treatment after localization.

Entities:  

Mesh:

Year:  2004        PMID: 15249450     DOI: 10.1378/chest.126.1.108

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

Review 1.  Lung cancer screening.

Authors:  Peter J Mazzone; Tarek Mekhail
Journal:  Curr Oncol Rep       Date:  2007-07       Impact factor: 5.075

Review 2.  Early central airways lung cancer.

Authors:  Chiaki Endo; Akira Sakurada; Takashi Kondo
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-07-19

Review 3.  The technique of endoscopic airway tumor treatment.

Authors:  Simone Scarlata; Lello Fuso; Gabriele Lucantoni; Francesco Varone; Daniele Magnini; Raffaele Antonelli Incalzi; Gianni Galluccio
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

4.  Simultaneous stereotactic body radiation therapy of a primary non-small cell lung cancer and synchronous carcinoma in situ in a medically inoperable patient: case report.

Authors:  Feras Oskan; Christine Kornhuber; Grit Krause; Dirk Vordermark
Journal:  Radiat Oncol       Date:  2013-09-13       Impact factor: 3.481

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.